CUSIP: 07160F107
Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,305,921
-
Share change
-
+1,036,628
-
Total reported value
-
$9,425,870
-
Put/Call ratio
-
15%
-
Price per share
-
$1.29
-
Number of holders
-
31
-
Value change
-
+$2,587,129
-
Number of buys
-
20
-
Number of sells
-
15
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2021
-
Previous quarter:
Q4 2020
Recent filing periods for CUSIP 07160F107:
Institutional Holders of BAUDAX BIO INC - COM (BXRX) as of Q1 2021
As of 31 Mar 2021,
BAUDAX BIO INC - COM (BXRX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,305,921 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, Brandywine Global Investment Management, LLC, TWO SIGMA ADVISERS, LP, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, Bank of New York Mellon Corp, and EDMOND DE ROTHSCHILD HOLDING S.A..
This page lists
31
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.